Results 221 to 230 of about 283,567 (361)

Acute Severe Hepatitis B Virus Infection in Previously Vaccinated Patient during Acalabrutinib Treatment. [PDF]

Emerg Infect Dis
Rojek L, Wnuk-Lipinski T, Marek I, Grabowski H, Adrych K.   +4 more
europepmc   +1 more source

Isolated Hepatitis B Core Antibody Is Associated with HIV and Ongoing but Not Resolved Hepatitis C Virus Infection in a Cohort of US Women

, 2007
Audrey L. French, Eva Operskalski, Marion G. Peters, Howard D. Strickler, Phyllis C. Tien, Gerald B. Sharp, Marshall J. Glesby, Mary Young, Michael Augenbraun, Eric C. Seaberg, Andrea Kovács   +10 more
openalex   +2 more sources

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma

International Journal of Cancer, EarlyView.
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott, Emma J. West, Rebecca J. Brownlie, Fay Ismail, Christy Ralph, Thomas Heineman, Matt Coffey, Alan A. Melcher, Alison Taylor, Salvatore Papa, Adel Samson   +10 more
wiley   +1 more source

Hepatitis E Infection in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. [PDF]

J Viral Hepat
Kogias D, Kouklakis G, Papadopoulos V.
europepmc   +1 more source

The Prevalence of Hepatitis C Virus Antibody in HIV-Negative Persons in Kenya, 2007 [PDF]

, 2018
Kathleen N. Ly, Andrea A. Kim, Jan Drobeniuc, Maja Kodani, Joel M. Montgomery, Barry S. Fields, Eyasu H. Teshale   +6 more
openalex   +1 more source

Real‐world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study

International Journal of Cancer, EarlyView.
What's New? Although patients with melanoma brain metastases (MBM) may benefit from treatment with immune checkpoint inhibitors (ICIs), which are known to improve survival in advanced melanoma, MBM patients have often been excluded from trials evaluating ICIs.
Ralf Gutzmer, Michael Weichenthal, Thomas Eigentler, Peter Mohr, Thomas Sickmann, Pia Dücker, Christoffer Gebhardt, Sebastian Haferkamp, Katharina C. Kähler, Friedegund Meier, Claudia Pföhler, Anca Sindrilaru, Patrick Terheyden, Imke von Wasielewski, Selma Ugurel, Jens Ulrich, Jochen Utikal, Carsten Weishaupt, Dirk Schadendorf   +18 more
wiley   +1 more source

Efficiency of decentralized screening for hepatitis C in different healthcare settings: retrospective study over 6 years in southeastern Spain. [PDF]

Transl Gastroenterol Hepatol
Ventero MP, Silva-Afonso R, Guerrero Soler M, Tyshkovska I, Escribano I, Parra M, Esteve A, Molina-Pastor F, Llorens P, Saiz P, Reus S, Merino E, Sánchez-Payá J, Rodríguez JC.   +13 more
europepmc   +1 more source

Additional file 2: of Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature

, 2017
Weiming Tang, Wen Chen, Ali Amini, Debi Boeras, Jane Falconer, Helen Kelly, Rosanna Ŵ. Peeling, Olivia Varsaneux, Joseph Tucker, Philippa Easterbrook   +9 more
openalex   +1 more source

A newly discovered controversial role of the neutralizing HCV antibodies in the relapse of hepatitis C virus [PDF]

, 2019
Salah Sh, Mubaraki AM, Ghaleb Ha, H Ehab, El-Hariri Hm   +4 more
openalex   +1 more source

Retrospective Analysis of Blood Donor Deferral Reasons and Optimization Suggestions for Deferral Policies

iLABMED, EarlyView.
This retrospective study analyzes the deferral reasons for 148,282 blood donors during 2019–2023 (overall deferral rate: 12.37%), identifying primary deferral reasons (e.g., elevated ALT for temporary deferral at 51.33%, HBsAg positivity for permanent deferral at 4.12%).
Limei Feng, Li Liu, Rui Wang, Ting Zhang, Wei Guo, Yang Yu   +5 more
wiley   +1 more source